title: Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model.
abstract: Neurogenesis is a life long process, but the rate of cell proliferation and differentiation decreases with age. In Alzheimer's patients, along with age, the presence of Aβ in the brain inhibits this process by reducing stem cell proliferation and cell differentiation. GLP-1 is a growth factor that has neuroprotective properties. GLP1 receptors are present on neuronal progenitor cells, and the GLP-1 analogue liraglutide has been shown to increase cell proliferation in an Alzheimer's disease (AD) mouse model. Here we investigated acute and chronic effects of liraglutide on progenitor cell proliferation, neuroblast differentiation and their subsequent differentiation into neurons in wild type and APP/PS-1 mice at different ages. APP/PS1 and their littermate controls, aged 3, 6, 12, 15 months were injected acutely or chronically with 25 nmol/kg liraglutide. Acute treatment with liraglutide showed an increase in cell proliferation in APP/PS1 mice, but not in controls whereas chronic treatment increased cell proliferation at all ages (BrdU and Ki67 markers). Moreover, numbers of immature neurons (DCX) were increased in both acute and chronic treated animals at all ages. Most newly generated cells differentiated into mature neurons (NeuN marker). A significant increase was observed with chronically treated 6, 12, 15 month APP/PS1 and WT groups. These results demonstrate that liraglutide, which is currently on the market as a treatment for type 2 diabetes (Victoza(TM)), increases neurogenesis, which may have beneficial effects in neurodegenerative disorders like AD.
authors.affiliation: School of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
authors.forename: Vadivel
authors.initials: V
authors.lastname: Parthsarathy
authors.forename: Christian
authors.initials: C
authors.lastname: Hölscher
mesh_terms: D000367:Age Factors; D000544:Alzheimer Disease / Q000378:metabolism*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004195:Disease Models, Animal; D000089662:Doublecortin Protein; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D000069450:Liraglutide; D051379:Mice; D055495:Neurogenesis / Q000187:drug effects*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*
chemical_list: C000714847:Dcx protein, mouse; D000089662:Doublecortin Protein; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1
references.citation: Behav Brain Res. 2009 Dec 14;205(1):265-71
references.pmid: 19573562
references.citation: Eur J Pharmacol. 2010 Mar 25;630(1-3):158-62
references.pmid: 20035739
references.citation: J Pharmacol Exp Ther. 2002 Mar;300(3):958-66
references.pmid: 11861804
references.citation: J Mol Neurosci. 2002 Feb-Apr;18(1-2):7-14
references.pmid: 11931352
references.citation: Diabetologia. 2002 Oct;45(10):1410-5
references.pmid: 12378382
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1971-6
references.pmid: 19188609
references.citation: Eur J Pharmacol. 2004 Apr 19;490(1-3):115-25
references.pmid: 15094078
references.citation: Exp Neurol. 2004 Aug;188(2):224-37
references.pmid: 15246822
references.citation: Neurosci Lett. 2004 Sep 16;368(1):7-10
references.pmid: 15342123
references.citation: Mol Neurobiol. 1989 Spring-Summer;3(1-2):71-100
references.pmid: 2553069
references.citation: Nat Rev Endocrinol. 2009 May;5(5):262-9
references.pmid: 19444259
references.citation: J Neuroinflammation. 2008 May 21;5:19
references.pmid: 18492290
references.citation: Mol Endocrinol. 2003 Feb;17(2):161-71
references.pmid: 12554744
references.citation: Nat Biotechnol. 2005 Jul;23(7):857-61
references.pmid: 16003374
references.citation: Neurosci Lett. 2006 Nov 27;409(1):24-9
references.pmid: 17018248
references.citation: Neurobiol Aging. 2006 Oct;27(10):1505-13
references.pmid: 16271278
references.citation: J Neurosci. 2006 May 31;26(22):5888-93
references.pmid: 16738230
references.citation: Prog Neurobiol. 2005 Apr;75(5):321-41
references.pmid: 15913880
references.citation: Cell. 2002 Aug 23;110(4):429-41
references.pmid: 12202033
references.citation: Curr Med Chem. 2007;14(22):2318-29
references.pmid: 17896980
references.citation: Nat Rev Neurol. 2009 Jun;5(6):311-22
references.pmid: 19498435
references.citation: Neurosci Lett. 2010 Dec 3;486(1):38-42
references.pmid: 20854877
references.citation: Brain Res. 2000 Sep 29;878(1-2):194-8
references.pmid: 10996151
references.citation: J Neurosci Res. 2008 Feb 1;86(2):326-38
references.pmid: 17803225
references.citation: J Neurosci Res. 2010 Aug 1;88(10):2103-17
references.pmid: 20209626
references.citation: J Alzheimers Dis. 2005 Feb;7(1):63-80
references.pmid: 15750215
references.citation: Brain Res. 2012 Apr 17;1449:83-93
references.pmid: 22418058
references.citation: Curr Alzheimer Res. 2006 Feb;3(1):25-8
references.pmid: 16472199
references.citation: Neurology. 2011 Jul 19;77(3):212-8
references.pmid: 21753171
references.citation: Curr Alzheimer Res. 2007 Apr;4(2):147-52
references.pmid: 17430239
references.citation: Stroke. 2006 Sep;37(9):2361-7
references.pmid: 16873711
references.citation: Exp Brain Res. 1988;72(2):399-406
references.pmid: 2465172
references.citation: J Clin Invest. 2012 Apr;122(4):1339-53
references.pmid: 22476196
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1285-90
references.pmid: 19164583
references.citation: Diabetes Obes Metab. 2009 Dec;11 Suppl 3:11-8
references.pmid: 19878257
references.citation: Curr Drug Targets. 2004 Aug;5(6):565-71
references.pmid: 15270203
references.citation: J Clin Invest. 2012 Apr;122(4):1316-38
references.pmid: 22476197
references.citation: Curr Alzheimer Res. 2006 Jul;3(3):185-90
references.pmid: 16842093
references.citation: Biochem Soc Trans. 2011 Aug;39(4):891-7
references.pmid: 21787319
references.citation: Biomol Eng. 2001 Jun;17(6):157-65
references.pmid: 11337275
references.citation: J Neurosci. 1999 Jul 15;19(14):5792-801
references.pmid: 10407020
references.citation: Curr Alzheimer Res. 2009 Apr;6(2):158-70
references.pmid: 19355851
references.citation: J Neurosci. 1996 Mar 15;16(6):2027-33
references.pmid: 8604047
references.citation: Nat Med. 2003 Sep;9(9):1173-9
references.pmid: 12925848
references.citation: Neuroreport. 2009 Aug 26;20(13):1161-6
references.pmid: 19617854
references.citation: Diabetes Obes Metab. 2010 Oct;12(10):891-9
references.pmid: 20920042
references.citation: J Comp Neurol. 1969 Dec;137(4):433-57
references.pmid: 5361244
references.citation: Neurobiol Aging. 2012 Feb;33(2):265-76
references.pmid: 20359773
references.citation: Eur J Pharmacol. 2004 Apr 19;490(1-3):127-33
references.pmid: 15094079
references.citation: J Neurochem. 2002 Dec;83(6):1509-24
references.pmid: 12472904
references.citation: Science. 2003 Dec 5;302(5651):1760-5
references.pmid: 14615545
references.citation: Physiol Rev. 2005 Apr;85(2):523-69
references.pmid: 15788705
references.citation: Neurosignals. 2006-2007;15(1):1-12
references.pmid: 16825799
references.citation: Brain Res Rev. 2007 Jan;53(1):198-214
references.pmid: 17020783
references.citation: Gastroenterology. 2007 May;132(6):2131-57
references.pmid: 17498508
references.citation: Neurobiol Aging. 2011 Mar;32(3):407-18
references.pmid: 19398247
references.citation: Radiat Res. 2004 Jul;162(1):39-47
references.pmid: 15222778
references.citation: Eur J Pharmacol. 2008 Jun 10;587(1-3):112-7
references.pmid: 18466898
references.citation: J Comp Neurol. 2001 Jul 9;435(4):406-17
references.pmid: 11406822
references.citation: J Neurosci. 2011 Apr 27;31(17):6587-94
references.pmid: 21525299
references.citation: BMC Neurosci. 2012 Mar 23;13:33
references.pmid: 22443187
references.citation: J Neurosci. 2005 Sep 21;25(38):8680-5
references.pmid: 16177036
references.citation: J Neurosci Res. 2011 Apr;89(4):481-9
references.pmid: 21312223
references.citation: J Neurosci. 2002 Jan 15;22(2):515-22
references.pmid: 11784797
references.citation: Neuroscience. 2005;130(4):843-52
references.pmid: 15652983
references.citation: Int J Obes (Lond). 2013 May;37(5):678-84
references.pmid: 22665137